After the isoxazoline gold rush: Where will industry turn for next big antiparasitic windfall?

摘要

The antiparasitic space has been an active battleground for the animal health industry for many decades. It is the largest single product market in animal health and will undoubtedly remain a key growth driver over the coming years. Animal Pharm editor Joseph Harvey canvassed opinion from a range of thought leaders on opportunities and challenges in this key blockbuster market.One variation will add a new therapeutic indication for both products - treatment of tick infestations with Ixodes hexagonus.The two products were originally developed by Merial and now lie in the Boehringer portfolio following the former's acquisition.